Last updated on June 2016

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.


Brief description of study

The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment

Detailed Study Description

The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment that would have the theoretical advantage of being well tolerated and more effective than chemotherapy alone even after an anti-aromatase therapy.

Clinical Study Identifier: NCT02585388

Contact Investigators or Research Sites near you

Start Over

Michèle TORRES-MACQUE

CHD Vend e
La Roche sur Yon, France
  Connect »